Literature DB >> 19727863

Probing possible egress channels for multiple ligands in human CYP3A4: a molecular modeling study.

Navaneethakrishnan Krishnamoorthy1, Poornima Gajendrarao, Sundarapandian Thangapandian, Yuno Lee, Keun Woo Lee.   

Abstract

Human cytochrome P450 (CYP) 3A4 extensively contributes to metabolize 50% of the marketed drugs. Recently, a CYP3A4 structure with two molecules of ketoconazole (2KT) was identified. However, channels for egresses of these inhibitors are unexplored. Thus, we applied molecular dynamics simulations followed by channel analyses. Two simulations of empty and 2KT-bound CYP3A4 results revealed the multiple ligand-induced conformational changes in channel forming regions, which appear to be important for the regulation of channels. In addition, we observed that the channel-3 entrance is closed due to the large structural deviation of the key residues from Phe-cluster. F215 and F220 are known as entrance blockers of channel-2 in metyrapone-bound CYP3A4. Currently, F220 blocks the channel-3 along with F213 and F241. Therefore, it suggested that channel-1 and 2 could potentially serve as egress routes for 2KT. It is also supported by the results from MOLAxis analyses, in which the frequency of channel occurrence and bottleneck radius during simulation favor channel-1 and 2. Several bottleneck residues of these channels may have critical roles in 2KT egresses, especially S119. Our modeling study for multiple ligand-channeling of CYP3A4 could be very helpful to gain new insights into channel selectivity of CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727863     DOI: 10.1007/s00894-009-0571-5

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  28 in total

1.  How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.

Authors:  S K Lüdemann; V Lounnas; R C Wade
Journal:  J Mol Biol       Date:  2000-11-10       Impact factor: 5.469

2.  Cytochrome P450 flexibility.

Authors:  Thomas L Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Possible pathway(s) of metyrapone egress from the active site of cytochrome P450 3A4: a molecular dynamics simulation.

Authors:  Weihua Li; Hong Liu; Xiaomin Luo; Weiliang Zhu; Yun Tang; James R Halpert; Hualiang Jiang
Journal:  Drug Metab Dispos       Date:  2007-01-24       Impact factor: 3.922

Review 5.  Cytochromes P450 and drug discovery.

Authors:  David C Lamb; Michael R Waterman; Steven L Kelly; F Peter Guengerich
Journal:  Curr Opin Biotechnol       Date:  2007-11-19       Impact factor: 9.740

6.  Inhibitor-induced conformational change in cytochrome P-450CAM.

Authors:  R Raag; H Li; B C Jones; T L Poulos
Journal:  Biochemistry       Date:  1993-05-04       Impact factor: 3.162

7.  Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.

Authors:  Pamela A Williams; Jose Cosme; Dijana Matak Vinkovic; Alison Ward; Hayley C Angove; Philip J Day; Clemens Vonrhein; Ian J Tickle; Harren Jhoti
Journal:  Science       Date:  2004-07-15       Impact factor: 47.728

Review 8.  Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.

Authors:  J Andrew Williams; Ruth Hyland; Barry C Jones; Dennis A Smith; Susan Hurst; Theunis C Goosen; Vincent Peterkin; Jeffrey R Koup; Simon E Ball
Journal:  Drug Metab Dispos       Date:  2004-08-10       Impact factor: 3.922

Review 9.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

10.  The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.

Authors:  Jason K Yano; Michael R Wester; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

View more
  6 in total

1.  The dynamics of camphor in the cytochrome P450 CYP101D2.

Authors:  Shabana Vohra; Maria Musgaard; Stephen G Bell; Luet-Lok Wong; Weihong Zhou; Philip C Biggin
Journal:  Protein Sci       Date:  2013-08-12       Impact factor: 6.725

Review 2.  Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 3.  Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Dalton Trans       Date:  2012-09-27       Impact factor: 4.390

4.  Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  J Med Chem       Date:  2013-04-26       Impact factor: 7.446

Review 5.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

6.  Induced fit for cytochrome P450 3A4 based on molecular dynamics.

Authors:  Israel Quiroga; Thomas Scior
Journal:  ADMET DMPK       Date:  2019-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.